CN106720787A - 一种降糖降压保健茶及其制备方法 - Google Patents
一种降糖降压保健茶及其制备方法 Download PDFInfo
- Publication number
- CN106720787A CN106720787A CN201611203947.8A CN201611203947A CN106720787A CN 106720787 A CN106720787 A CN 106720787A CN 201611203947 A CN201611203947 A CN 201611203947A CN 106720787 A CN106720787 A CN 106720787A
- Authority
- CN
- China
- Prior art keywords
- extract
- preparation
- blood pressure
- health tea
- liquid ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 28
- 230000036541 health Effects 0.000 title claims abstract description 22
- 230000036772 blood pressure Effects 0.000 title claims abstract description 21
- 230000000881 depressing effect Effects 0.000 title claims abstract description 18
- 241001122767 Theaceae Species 0.000 title description 13
- 239000000284 extract Substances 0.000 claims abstract description 38
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- 240000000249 Morus alba Species 0.000 claims abstract description 15
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 240000008042 Zea mays Species 0.000 claims abstract description 13
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 11
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 10
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 9
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 9
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 9
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 9
- 244000302512 Momordica charantia Species 0.000 claims abstract description 8
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 8
- 235000007244 Zea mays Nutrition 0.000 claims abstract description 7
- 229940089639 cornsilk Drugs 0.000 claims abstract description 7
- 235000020717 hawthorn extract Nutrition 0.000 claims abstract description 7
- 239000001231 zea mays silk Substances 0.000 claims abstract description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 6
- 235000005822 corn Nutrition 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims abstract 11
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract 3
- 239000007788 liquid Substances 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 12
- 238000012216 screening Methods 0.000 claims description 12
- 240000005250 Chrysanthemum indicum Species 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 244000241872 Lycium chinense Species 0.000 claims description 3
- 235000015468 Lycium chinense Nutrition 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 21
- 239000003814 drug Substances 0.000 abstract description 13
- 244000241838 Lycium barbarum Species 0.000 abstract description 5
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 235000008216 herbs Nutrition 0.000 abstract description 4
- 208000001953 Hypotension Diseases 0.000 abstract description 3
- 230000003276 anti-hypertensive effect Effects 0.000 abstract description 3
- 208000021822 hypotensive Diseases 0.000 abstract description 3
- 230000001077 hypotensive effect Effects 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 235000013339 cereals Nutrition 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 235000019640 taste Nutrition 0.000 abstract description 2
- 206010030113 Oedema Diseases 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 239000012467 final product Substances 0.000 description 14
- 238000009835 boiling Methods 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 206010020772 Hypertension Diseases 0.000 description 8
- 241000219051 Fagopyrum Species 0.000 description 7
- 239000002904 solvent Substances 0.000 description 6
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 5
- 230000001603 reducing effect Effects 0.000 description 5
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical group O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 5
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 5
- 235000005493 rutin Nutrition 0.000 description 5
- 229960004555 rutoside Drugs 0.000 description 5
- 238000001694 spray drying Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000004153 islets of langerhan Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 229910001369 Brass Chemical class 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- OVVGHDNPYGTYIT-ROUHPGRKSA-N alpha-L-Rhap-(1->6)-D-Glcp Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 OVVGHDNPYGTYIT-ROUHPGRKSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000010951 brass Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种降糖降压保健茶及其制备方法，保健茶包括以下重量份的原料：苦瓜提取物5‑15份、苦荞提取物20‑30份、桑叶提取物15‑30份、枸杞子提取物10‑20份、菊花提取物10‑20份、玉米须提取物5‑15份、山楂提取物5‑10份。苦荞是我国药食同源文化的典型体现，被誉为“五谷之王”，三降食品。利用苦瓜的养血滋肝，桑叶的清肺润燥，枸杞的滋补肝肾，配合菊花的清热解毒，玉米须的利尿消肿、降血压的作用。再加入山楂调整整体口感。本发明中的各味中药相互影响，协同作用，具有较好的降糖降压功效。同时本发明所用药材均无毒无害，溶解度大，使用方便，可放心饮用。
Description
技术领域
本发明涉及食品领域，具体的涉及一种降糖降压保健茶及其制备方法。
背景技术
糖尿病是一种以高血糖为特征的代谢性疾病。高血糖则是由于胰岛素分泌缺陷或其生物作用受损，或两者兼有引起。糖尿病时长期存在的高血糖，导致各种组织，特别是眼、肾、心脏、血管、神经的慢性损害、功能障碍。但是对于糖尿病人而言，西药治疗有较多的毒副作用，而对用中药治疗，通常熬药又是很耽误时间的事情，因此能够有一种能够替代中药的茶饮，则不仅克服上述的缺陷，还能起到降血糖的保健效果。
苦荞麦味苦，性平寒，益气力，利耳目，有降气宽肠健胃的作用。现代临床医学观察表明，苦荞麦粉及其制品具有降血糖、降血脂，增强人体免疫力的作用，对糖尿病、高血压、高血脂、冠心病、中风等病人都有辅助治疗作用。据科学工作者证实，苦荞中含有黄酮类物质，其主要成分为芦丁。芦丁含量占总黄酮的70～90％，具有降低毛细血管脆性，改善微循环的作用，在临床上主要用于糖尿病、高血压的辅助治疗。而芦丁在其它谷物中几乎没有。苦荞其所含芦丁可软化血管，具有降血脂、降血糖、降血压，减肥败毒、清理人体垃圾、激活胰岛素分泌等功效。
桑叶是植物之王，有“人参热补，桑叶清补”之美誉，桑叶中含有1-脱氧野尻霉素(DNJ)。具有抑制血糖上升的药理作用，可用于防治和治疗糖尿病。还含有强化毛细血管、降低血液粘度的黄酮类成分，所以在减肥、改善高脂血症的同时，又有预防心肌梗塞和脑溢血的作用。另外，桑叶中所含的槲皮素、酚类化合物、维生素C等成分能通过抑制或清除自由基来防止氧化损伤。桑叶具有类似人参的补益与抗衰老、稳定神经系统功能的作用，能缓解生理变化引起的情绪激动，提高体内超氧化物歧化酶的活性，阻止体内有害物质的产生，减少或消除已经产生并积滞于体内的脂褐质。桑叶属于清补，无忌限，无论老幼均可使用，且四季皆宜。
发明内容
发明目的：本发明的目的在于提供一种能有效辅助治疗糖尿病的降糖茶，减少糖尿病患者药物或胰岛素的用量，阻止或延缓病发症的发生，减轻糠尿病病人心理痛苦。另外，本发明的茶饮还具有降压降脂作用。
为了解决上述技术问题，本发明所采用的技术方案为：
一种降糖降压保健茶，以重量份计，包括：
其中，所述苦瓜提取物、枸杞子提取物、菊花提取物和玉米须提取物为水提物；所述苦荞提取物、桑叶提取物和山楂提取物为醇提物。
水提取可提取出苦瓜中的多糖、氨基酸、蛋白质等有效水溶性成份；枸杞果实含有丰富的维生素B1、B2、C以及多种氨基酸成分，可用水提取得到，在药理上有降低血糖、胆固醇的作用，并可扩张血管，降低血压；菊花用水提取可提出含菊甙、维生素A样物质及菊花酮等挥发油，能疏散风热，清肝明目的作用。能明显扩张冠状动脉，可增强毛细血管抵抗力；玉米须中的黄酮类、苦味糖苷、氨基酸等均可用水提取得到；乙醇提取苦荞麦可得到芦丁、槲皮素、山柰酚、山柰酚-3-0芸香糖苷等有效成分，有软化血管、降血糖、血脂、益气提神、加强胰岛素等外周作用；桑叶中最有利人体健康的有生物碱类、植物甾醇和γ-氨基丁酸，这些成分用醇提效果最好；山楂果实含左旋儿表茶精、槲皮素、绿原酸，枸橼酸等有降血脂作用的有机酸类，适合用醇提取。所述的醇提物具体可以为乙醇提取物。
本发明提供的降糖降压保健茶中：
苦荞是我国药食同源文化的典型体现。是集“营养、保健、医疗”于一体的天然功能食品。《本草纲木》有“降气宽肠磨积滞,消热肿风痛,除白浊血滞,脾积泄泻”的论述。苦荞能降血压、降血糖、降血脂,改善微循环等作用,又称“三降”食品。而苦瓜粗提取物含类似胰岛素物质，有明显的降血糖作用。中医认为，苦瓜性味甘苦寒凉，能清热、除烦、止渴的功效。现代中、西医把桑叶和桑叶生物制剂作为改善糖尿病及其他各种疑难杂症的药物而使用，认为其药效极为广泛。原料中的枸杞也具有降血糖、血脂的作用，其中的枸杞多糖能明显增强受损胰岛细胞内超氧化物歧化酶的活性，提高胰岛细胞的抗氧化能力，减轻过氧化物对细胞的损伤，降低内二醛生成量，这表明枸杞多糖对胰岛细胞有一定的保护作用。另外玉米须也有降压、降糖、利胆和止血等保健作用。菊花疏风较弱，清热力佳，用于外感风热常配桑叶同用，菊花治目赤肿痛，无论属于肝火或风热引起者，均可应用。山楂有重要的药用价值，自古以来，就成为健脾开胃、消食化滞、活血化痰的良药。目前，已有50多种中药配方以山楂作原料。山楂中含有山萜类及黄铜类等药物成分，具有显著的扩张血管及降压作用，有增强心肌、抗心律不齐、调节血脂及胆固醇含量的功能。另外，山楂和枸杞还能调节口感。
所述苦瓜提取物的制备方法包括：将苦瓜置于90-100℃水中提取1-2h，提取料液比为1:9-11，提取结束后过滤，滤液干燥过筛。
进一步的，所述苦瓜提取物的制备方法包括：苦瓜洗净切碎，第一次按料液比1:10的比例，沸水提取1小时，趁热过滤，第二次按料液比1:8的比例，沸水提取1小时，趁热过滤，合并两次滤液，浓缩，真空干燥，过80目筛，即得。
所述苦荞提取物的制备方法包括：将苦荞置于55-65％乙醇中于70-80℃进行回流提取2-3h，提取料液比为1：25-30，提取结束后过滤，滤液干燥过筛。
进一步的，所述苦荞提取物的制备方法包括：苦荞洗净，提取溶剂为60％乙醇，75℃回流提取2小时，趁热过滤，按上述步骤提取三次，合并三次滤液，浓缩，喷雾干燥，过80目筛，即得。
所述桑叶提取物的制备方法包括：将桑叶置于75-85％乙醇中，于55-65℃提取2-3h，提取料液比为1：19-21，提取结束后过滤，滤液干燥过筛。
进一步的，所述桑叶提取物的制备方法包括：桑叶洗净切碎，提取溶剂为80％的乙醇，按料液比1:20的比例，60℃提取2小时，趁热过滤，浓缩，恒温干燥，过80目筛，即得。
所述枸杞子提取物的制备方法包括：将枸杞子置于90-100℃水中提取1-2h，提取料液比为1:9-11，提取结束后过滤，滤液干燥过筛。
进一步的，所述枸杞子提取物的制备方法包括：枸杞洗净，按料液比1:10的比例，沸水提取1小时，趁热过滤，第二次按料液比1:8的比例，沸水提取1小时，趁热过滤，合并两次滤液，浓缩，喷雾干燥，过80目筛，即得。
所述菊花提取物的制备方法包括：将菊花置于90-100℃水中提取0.5-1h，提取料液比为1:9-11，提取结束后过滤，滤液干燥过筛。
进一步的，所述菊花提取物的制备方法包括：菊花洗净，第一次按料液比1:10的比例，沸水提取40分钟，趁热过滤，第二次按料液比1:8的比例，沸水提取40分钟，趁热过滤，合并两次滤液，浓缩，真空干燥，过80目筛，即得。
所述玉米须提取物的制备方法包括：将玉米须置于75-85℃水中提取2-3h，提取料液比为1:25-35，提取结束后过滤，滤液干燥过筛。
进一步的，所述玉米须提取物的制备方法为：玉米须洗净，按料液比1：30的比例，80℃水温提取2小时，趁热过滤，浓缩，喷雾干燥，过80目筛，即得。
所述山楂提取物的制备方法包括：将山楂置于55-65％乙醇中于65-75℃提取1-2h，提取料液比为1：19-21，提取结束后过滤，滤液干燥过筛。
进一步的，所述山楂提取物的制备方法为：山楂洗净切碎去核，提取溶剂为60％乙醇，按料液比1:20的比例，70℃提取1小时，趁热过滤，重复两次，合并两次滤液，浓缩，冷冻干燥，过80目筛，即得。
进一步的，所述降糖降压保健茶，以重量份计，包括：
所述降糖降压保健茶为加水即饮的固体饮料。
本发明还提供了上述降糖降压保健茶的制备方法，该方法包括以下步骤:按照配比称取各组分，混合均匀，分装。
与现有技术相比，本发明的有益效果为：
本发明造福糖尿病患者，让其能够多一种选择。其中的各味中药相互影响，协同作用，具有较好的降糖降压功效。同时本发明所用药材均无毒无害，溶解度大，使用方便。
本发明是复合型袋泡茶，携带方便，而且可以重复饮用。
具体实施方式
下面结合具体实施例，进一步阐明本发明，应理解这些实施例仅用于说明本发明而不用于限制本发明的范围，在阅读了本发明之后，本领域技术人员对本发明的各种等价形式的修改均落于本申请所附权利要求所限定的范围。
本发明中涉及的料液比的单位为g/ml。
苦瓜提取物的制备方法为：苦瓜洗净切碎，第一次按料液比1:10的比例，沸水提取1小时，趁热过滤，第二次按料液比1:8的比例，沸水提取1小时，趁热过滤，合并两次滤液，浓缩，真空干燥，过80目筛，即得。
苦荞提取物的制备方法为：苦荞洗净，提取溶剂为60％乙醇，料液比为1：25，75℃回流提取2小时，趁热过滤，按上述步骤提取三次，合并三次滤液，浓缩，喷雾干燥，过80目筛，即得。
桑叶提取物的制备方法为：桑叶洗净切碎，提取溶剂为80％的乙醇，按料液比1:20的比例，60℃提取2小时，趁热过滤，浓缩，恒温干燥，过80目筛，即得。
枸杞子提取物的制备方法为：枸杞洗净，按料液比1:10的比例，沸水提取1小时，趁热过滤，第二次按料液比1:8的比例，沸水提取1小时，趁热过滤，合并两次滤液，浓缩，喷雾干燥，过80目筛，即得。
菊花提取物的制备方法为：菊花洗净，第一次按料液比1:10的比例，沸水提取40分钟，趁热过滤，第二次按料液比1:8的比例，沸水提取40分钟，趁热过滤，合并两次滤液，浓缩，真空干燥，过80目筛，即得。
玉米须提取物的制备方法为：玉米须洗净，按料液比1：30的比例，80℃水温提取2小时，趁热过滤，浓缩，喷雾干燥，过80目筛，即得。
山楂提取物的制备方法为：山楂洗净切碎去核，提取溶剂为60％乙醇，按料液比1:20的比例，70℃提取1小时，趁热过滤，重复两次，合并两次滤液，浓缩，冷冻干燥，过80目筛，即得。
实施例1-6
1、组成：见表1
表1：实施例1-6组成(单位：g)
2、制备方法：按照配比称取各组分，于混合机中充分混合，再按规定装量分装。
实施例7
1、一般资料：
2016年1月～2016年6月期间共收集了30例高血压高血脂患者，其中，男15例，女15例，年龄50～80岁，病程不等。采用随机抽取法随机分为治疗组和对照组各15例，两组性别、年龄、病程等各项资料无显著性差异，具有可比性。
2、试验方法：
对照组饮用普通的袋泡茶，连续服用60天。治疗组饮用本发明中的实施例4，一日至少饮用两次，连续服用60天。
3、疗效标准：
好转：脸色红润，精神饱满，血压、血脂基本回到正常指标(本品为健康复合型茶饮，不存在完全治愈)
无效：症状毫无消失或加重
4、治疗结果：
60天后观察治疗结果，治疗组好转15例，无效0例，有效率为100％。对照组好转7例，无效8例，有效率为47％。治疗组的有效率明显高于对照组。表明本发明的新型袋泡茶是一种健康的降压茶饮，能明显感到身体机制增强，血压血脂等基本恢复正常指标。
典型案例：
病例一：陈某，男，51岁，患有10多年的脂肪肝，后来查出有高血压、高血脂、高血糖等病症，手足发冷，脸色发黄，精神差，吃过多种药物，效果不明显。后改服用本发明例3，一天两袋，一袋冲多次，连续服用60天后，脸色红润，精神饱满，高血压、高血脂、高血糖等症状基本控制正常，继续服用90天后，到医院检查，发现脂肪肝的范围明显变小，身体抵抗力也有增强。
病例二：王某，男，56岁，患心脑血管病、高血脂病十多年，并伴有高血压，服用过多种新药、特效药，效果均不理想。后改服用本发明例4，服用60天后，左侧腿脚麻木的症状已消失，胸口不闷了，高血脂、高血压症状均回到正常指标，记忆力明显要好，大脑反应也快许多。
病例三：卢某，女，55岁，有糖尿病史5年，并伴有高血压，平时服用过多种药物，效果均不理想，空腹血糖指数控制在7.5mmol/L左右。后饮服本发明例4，一天三次，服用60天后，空腹血糖控制在5mmol/L以下，脸色渐变红润，精神饱满起来，并且明显感到身体的体制增强。
Claims (9)
1.一种降糖降压保健茶，其特征在于，以重量份计，包括：
其中，所述苦瓜提取物、枸杞子提取物、菊花提取物和玉米须提取物为水提物；所述苦荞提取物、桑叶提取物和山楂提取物为醇提物。
2.根据权利要求1所述的降糖降压保健茶，其特征在于，所述苦瓜提取物的制备方法包括：将苦瓜置于90-100℃水中提取1-2h，提取料液比为1:9-11，提取结束后过滤，滤液干燥过筛。
3.根据权利要求1所述的降糖降压保健茶，其特征在于，所述苦荞提取物的制备方法包括：将苦荞置于55-65％乙醇中于70-80℃进行回流提取2-3h，提取料液比为1：25-30，提取结束后过滤，滤液干燥过筛。
4.根据权利要求1所述的降糖降压保健茶，其特征在于，所述桑叶提取物的制备方法包括：将桑叶置于75-85％乙醇中，于55-65℃提取2-3h，提取料液比为1：19-21，提取结束后过滤，滤液干燥过筛。
5.根据权利要求1所述的降糖降压保健茶，其特征在于，所述枸杞子提取物的制备方法包括：将枸杞子置于90-100℃水中提取1-2h，提取料液比为1:9-11，提取结束后过滤，滤液干燥过筛。
6.根据权利要求1所述的降糖降压保健茶，其特征在于，所述菊花提取物的制备方法包括：将菊花置于90-100℃水中提取0.5-1h，提取料液比为1:9-11，提取结束后过滤，滤液干燥过筛。
7.根据权利要求1所述的降糖降压保健茶，其特征在于，所述玉米须提取物的制备方法包括：将玉米须置于75-85℃水中提取2-3h，提取料液比为1:25-35，提取结束后过滤，滤液干燥过筛。
8.根据权利要求1所述的降糖降压保健茶，其特征在于，所述山楂提取物的制备方法包括：将山楂置于55-65％乙醇中于65-75℃提取1-2h，提取料液比为1：19-21，提取结束后过滤，滤液干燥过筛。
9.根据权利要求1-8任一项所述的降糖降压保健茶的制备方法，其特征在于，包括:按照配比称取各组分，混合均匀，分装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611203947.8A CN106720787A (zh) | 2016-12-23 | 2016-12-23 | 一种降糖降压保健茶及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611203947.8A CN106720787A (zh) | 2016-12-23 | 2016-12-23 | 一种降糖降压保健茶及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106720787A true CN106720787A (zh) | 2017-05-31 |
Family
ID=58900125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611203947.8A Pending CN106720787A (zh) | 2016-12-23 | 2016-12-23 | 一种降糖降压保健茶及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106720787A (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296135A (zh) * | 2017-08-09 | 2017-10-27 | 李凯 | 一种降糖、降压的保健茶及其制备方法 |
| CN108835636A (zh) * | 2018-07-17 | 2018-11-20 | 广州汝丽多食品科技有限公司 | 一种辅助降血糖的山楂保健食品 |
| CN108936662A (zh) * | 2018-08-07 | 2018-12-07 | 广州汝丽多食品科技有限公司 | 一种辅助降血糖的苦瓜保健食品的制备方法 |
| CN110029037A (zh) * | 2019-04-23 | 2019-07-19 | 江苏伊贝实业股份有限公司 | 一种与按摩鞋协同作用的养生酒及其制备方法 |
| CN111296597A (zh) * | 2018-12-11 | 2020-06-19 | 马琳琳 | 一种保健茶饮及其制备方法 |
| CN112616973A (zh) * | 2020-12-28 | 2021-04-09 | 安徽致鑫中药饮片有限公司 | 一种具有降糖功效的苦瓜代用茶的制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102907604A (zh) * | 2012-11-09 | 2013-02-06 | 刘东元 | 一种降糖、降压、减肥、通便养颜、抗疲劳保健品及其生产工艺 |
| CN105267755A (zh) * | 2015-11-19 | 2016-01-27 | 刘庆华 | 降糖口服液 |
-
2016
- 2016-12-23 CN CN201611203947.8A patent/CN106720787A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102907604A (zh) * | 2012-11-09 | 2013-02-06 | 刘东元 | 一种降糖、降压、减肥、通便养颜、抗疲劳保健品及其生产工艺 |
| CN105267755A (zh) * | 2015-11-19 | 2016-01-27 | 刘庆华 | 降糖口服液 |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296135A (zh) * | 2017-08-09 | 2017-10-27 | 李凯 | 一种降糖、降压的保健茶及其制备方法 |
| CN108835636A (zh) * | 2018-07-17 | 2018-11-20 | 广州汝丽多食品科技有限公司 | 一种辅助降血糖的山楂保健食品 |
| CN108835636B (zh) * | 2018-07-17 | 2021-11-26 | 广州汝丽多食品科技有限公司 | 一种辅助降血糖的山楂保健食品 |
| CN108936662A (zh) * | 2018-08-07 | 2018-12-07 | 广州汝丽多食品科技有限公司 | 一种辅助降血糖的苦瓜保健食品的制备方法 |
| CN108936662B (zh) * | 2018-08-07 | 2022-06-14 | 广州汝丽多食品科技有限公司 | 一种辅助降血糖的苦瓜保健食品的制备方法 |
| CN111296597A (zh) * | 2018-12-11 | 2020-06-19 | 马琳琳 | 一种保健茶饮及其制备方法 |
| CN110029037A (zh) * | 2019-04-23 | 2019-07-19 | 江苏伊贝实业股份有限公司 | 一种与按摩鞋协同作用的养生酒及其制备方法 |
| CN112616973A (zh) * | 2020-12-28 | 2021-04-09 | 安徽致鑫中药饮片有限公司 | 一种具有降糖功效的苦瓜代用茶的制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106720787A (zh) | 一种降糖降压保健茶及其制备方法 | |
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN103609992B (zh) | 一种高丽红参膏的制备方法 | |
| KR100451665B1 (ko) | 홍화씨를 주성분으로 한 건강식품의 제조방법 및 건강식품 | |
| CN107996757A (zh) | 一种降血压、降血糖、降血脂、降胆固醇的保健饮品及其制备方法 | |
| KR20140097961A (ko) | 숙취해소 음료 | |
| CN101238909B (zh) | 一种鹰嘴豆豆芽汁及制备方法和用途 | |
| CN109430612A (zh) | 一种红枣枸杞汁及其生产方法 | |
| CN109170014A (zh) | 一种石斛保健茶及其制备方法 | |
| CN107048160A (zh) | 一种糖尿病人适用的果蔬米粉制品及其制备方法 | |
| KR20110080817A (ko) | 건강음료 조성물 및 그 제조방법 | |
| CN104798950A (zh) | 免疫功夫茶及其制备方法 | |
| EP1968401B1 (en) | Functional food composition for treating allergy, natural tea using the same and the manufacturing method thereof | |
| CN106579109A (zh) | 一种解酒护肝柑橘粉的组合物及其制备方法 | |
| CN106579108A (zh) | 含柑橘粉的组合物及其制备方法 | |
| CN105831318A (zh) | 一种多肽降糖茶及其制作方法 | |
| CN105341944A (zh) | 一种提高免疫力的丹参口服液及其制备方法 | |
| CN104026295B (zh) | 一种降血压血糖保健茶 | |
| CN106692760A (zh) | 一种预防糖尿病的金花酒配方及其制备方法 | |
| CN102860378A (zh) | 一种降压保健柿子醋茶饮料及其制备方法 | |
| CN109170052A (zh) | 一种石斛养胃保健茶及其制备方法 | |
| CN104606571A (zh) | 一种生津止渴鲜菠菜根代茶饮及制备方法 | |
| CN103919229A (zh) | 一种安眠定神保健速溶粉及其制备方法 | |
| CN103750425A (zh) | 一种高丽红参罗汉果汤的制备方法 | |
| CN108887658A (zh) | 一种治疗糖尿病的保健酱油及其制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |